News | May 25, 2022
IPCA Laboratories posts Rs. 130.23 crores consolidated profit in Q4FY22
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI
The drug will be available in 600 hospitals and 105 DTPs
AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology
The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking
The company enters into collaborations with leading next-generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
The workshop was organized by the Department of Urology as a first step to enabling government medical colleges in Rajasthan to offer the latest surgical technology
This RT-PCR diagnostic kit helps in diagnosis of AS by detecting HLAB27 gene
Subscribe To Our Newsletter & Stay Updated
